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Although current national response plans assume that 
most inﬂ   uenza-infected patients would stay home during 
a pandemic, surveillance systems might be overwhelmed 
and unable to monitor their health status. We explored the 
feasibility of using a nationwide telephone survey to moni-
tor at-home patients. Of randomly selected adults surveyed 
during low inﬂ   uenza activity months (April–October 2006, 
surveillance weeks 17–41), 86% (7,268/8,449) agreed to an-
swer questions about health status and inﬂ  uenza-like illness 
symptoms. Three percent (230/7,628) self-reported “ﬂ  u.” A 
subset (0.9%, 68/230) self-reported fever. In comparison, the 
Centers for Disease Control and Prevention’s Sentinel Pro-
vider Network reported clinical inﬂ  uenza-like illness rates of 
1.2%, 0.9%, and 1.2% for weeks 17, 20, and 41, respectively. 
The consistency between information obtained by telephone 
and surveillance data warrants further studies to determine 
whether telephone surveys can accurately monitor health 
status during seasonal inﬂ  uenza peaks and to augment cur-
rent surveillance systems during a pandemic.
T
he US Department of Health and Human Services 
(DHHS), Centers for Disease Control and Prevention 
(CDC), and other government agencies have been working 
to strengthen public health systems and improve strategies 
for monitoring and controlling pandemic inﬂ  uenza. Ac-
cording to the US Homeland Security Council’s National 
Strategy for Pandemic Inﬂ  uenza Implementation Plan, “... 
the public health community must have situational aware-
ness of the evolution of disease that can only come from 
connectivity to the emergency departments and other acute 
care settings where patients with inﬂ  uenza are presenting. 
The interpandemic period presents an opportunity to estab-
lish and test these relationships” (1). 
CDC currently supports the inﬂ  uenza surveillance re-
porting systems listed in Table 1 (2,3). Surveillance goals 
of the DHHS pandemic inﬂ  uenza plan are to 1) provide an 
early-warning system; 2) detect increases in inﬂ  uenza-like 
illness (ILI) at the local level; 3) monitor the impact of 
inﬂ  uenza on health (e.g., track outpatient visits, hospital-
izations, and deaths);  4) track trends in inﬂ  uenza disease 
activity; and 5) identify severely affected populations (3). 
Outpatient surveillance of ILI is emphasized at the na-
tional, regional, and state levels through CDC’s Sentinel 
Provider Network (SPN), which gathers and summarizes 
inﬂ  uenza illness surveillance reports from ≈2,300 health-
care providers nationwide (2). CDC plans to analyze daily 
reports of ambulatory patients with inﬂ  uenza that are ac-
cessed through the BioSense surveillance system (4,5) 
and use existing emergency department symptom-moni-
toring systems (2). This approach will strengthen systems 
that support situational awareness of inﬂ  uenza outbreaks, 
support geographic completeness and frequency of report-
ing, and ensure sustainable collection of ILI data during 
a pandemic. 
The DHHS Pandemic Inﬂ  uenza Plan notes that “most 
patients with pandemic inﬂ  uenza will be able to remain at 
home during the course of their illness and can be cared for 
by other family members or others who live in the house-
hold” (6). Local health districts, although responsible for 
monitoring the care of these at-home patients and maintain-
ing continuity of services, may be too overwhelmed to do 
so.  Because of the expected high demand for medical ser-
vices during a pandemic inﬂ  uenza emergency, SPN provid-
ers may also be overwhelmed, may have difﬁ  culty ﬁ  nding 
time to report outpatient ILI status in a timely manner, and 
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may be unable to monitor ILI patients at home (4). Inad-
equate surveillance will result in reduced situational aware-
ness at local, state, and federal levels. Currently, none of 
the functioning federal public health systems has plans in 
place to identify or monitor the health status of at-home 
patients with ILI symptoms.
We investigated whether a national telephone survey 
system would be feasible to ﬁ  ll the gap in surveillance. To 
determine whether national and local situational awareness 
of inﬂ  uenza could be improved by monitoring at-home pa-
tients in a systematic way, we partnered with a public opin-
ion research company to administer and analyze the results 
of a telephone survey. We report the results of that survey.
Methods
Using national pandemic inﬂ   uenza planning docu-
ments, CDC guidance, and the recent medical literature, we 
developed a telephone survey questionnaire (Table 2) that 
asked “Do you have the ﬂ  u?” and questions about symp-
toms such as fever, cough, and sore throat. This design al-
lows comparison of the survey data with the SPN’s deﬁ  ni-
tion of ILI (i.e., fever [>100°F (37.8°C)] and cough and/or 
sore throat in the absence of a known cause other than in-
ﬂ  uenza). Possible risk factors for exposure to novel avian 
inﬂ  uenza strains through live poultry (7), foreign travel 
(8,9), and cats (10) were also addressed in the survey. 
To explore the feasibility of using this telephone sur-
vey, we partnered with Zogby International (Utica, NY, 
USA) (11), a private public opinion research company 
experienced at collecting extensive demographic and so-
cioeconomic information through nationwide telephone 
surveys. A protocol to perform telephone surveys was 
submitted January 11, 2006 for institutional review board 
(IRB) review, subsequent questionnaire modiﬁ  cations were 
approved March 20, 2006, and the ﬁ  rst survey was com-
pleted the week of April 24, 2006, ≈110 days later. Month-
ly,  ≈1,205 randomly selected adults, who were already 
providing demographic and socioeconomic information for 
other Zogby International telephone surveys, were asked to 
participate in a research study about inﬂ  uenza. Participants 
answered follow-up questions over 5-day intervals ending 
on each of the following dates in 2006 (corresponding to 
CDC inﬂ  uenza surveillance calendar weeks) (12): April 24 
(week 17); May 16 (week 20); June 6 (week 23); July 25 
(week 30); August 15 (week 33); September 14 (week 37); 
130  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 1, January 2008
Table 1. Current infl n*
System Description 
Reporting
frequency 
uenza surveillance systems reporting to the US Centers for Disease Control and Preventio
Sentinel Provider Network (SPN)   Reports percentage of outpatient visits for influenza-like illness and total 
patients seen for any reason from a network of 2,300 nationwide 
healthcare providers 
Weekly 
Emerging Infections Program (EIP)  Reports laboratory-confirmed influenza-associated hospitalizations of 
children <18 years of age in 11 US communities 
Biweekly 
New Vaccine Surveillance Network (NVSN)   Reports laboratory-confirmed influenza-associated hospitalizations of 
children <5 years of age in 3 US communities 
Biweekly 
122 Cities Mortality Reporting System   Reports pneumonia- and influenza-related deaths and total no. deaths 
in 122 US cities 
Weekly 
National Notifiable Disease Surveillance 
System (NNDSS)  
Reports influenza-associated pediatric deaths recorded by participating 
state health departments 
Weekly 
State and Territorial Epidemiologists Report   Reports overall level of influenza activity in respective states, territories, 
or both 
Weekly 
US World Health Organization and Global 
Influenza Surveillance Network; National 
Respiratory and Enteric Virus Surveillance 
System (NREVSS) 
Report no. influenza laboratory tests performed and no. positive results 
by type and, in some cases, subtype 
Weekly 
*See (2,3).
Table 2. Telephone survey questions* 
A. Do you have a cat(s)? 
 A.1.  How  many? 
  A.2.  How many are recently sick?  
  A.3.  How many have died?  
B. Do you have chickens?  
  B.1.  What proportion, if any, are sick?  
  B.2.  Have there been more deaths of chickens than usual this 
week? 
C. Now we would like to ask you a few questions related to a 
research study conducted by the University of Texas Science 
Center at Houston. Are you willing to participate? 
  C.1.  Do you have the flu? 
  C.1.1.  Have you received your flu shot this year? 
  C.1.2.  What is your body temperature (fever)? 
  C.1.2.  Do any of your contacts have flu? 
  C.1.3.  Do you have shaking chills? 
  C.1.4.  Do you have body aches and muscle pain, in the back, 
arms or legs? 
  C.1.5.  Do you have a cough? 
  C.1.6.  Do you have a runny nose? 
 C.1.7.  Are  you  short-winded? 
  C.1.8.  Do you have a sore throat? 
  C.1.9.  Have you traveled to Southeast Asia recently? 
  C.1.10. How long have you had these symptoms? 
*Questions A–C were asked of all adults taking the telephone survey. Only 
respondents who answered “yes” to Question C were asked Question C.1; 
only respondents who answered “yes” to C.1 were asked the follow-up 
questions C.1.1 through C.1.10. Telephone Survey to Assess Inﬂ  uenza-like Illness
and October 12 (week 41). These dates were selected as 
a convenience sample based upon having received neces-
sary IRB approvals and having the availability of telephone 
survey capacity by our telephone surveying partners. Tele-
phone numbers for the surveys were randomly selected 
from commercially available national data sets of residen-
tial directory-listed telephone numbers. The probability 
of selection for the telephone survey was adjusted to be 
proportional to population sizes within area codes and tele-
phone exchanges. As many as 6 calls were made to reach a 
sampled phone number, and the procedures did not result 
in the same telephone numbers selected to be surveyed for 
each subsequent month.
One adult from each randomly sampled household was 
asked to answer the survey questionnaire by telephone. All 
interviews were conducted by Zogby International’s gen-
eral interviewers, who are monitored by supervisors to as-
sess adherence to surveying standards. For this study, the 
interviewer-to-supervisor ratio was  12:1. Quality control 
checks of interviewer performance were conducted on 10% 
of all calls. The survey was performed according to a pro-
tocol created by medical researchers at the University of 
Texas Health Science Center at Houston and approved by 
the university’s Institutional Review Board. Survey results 
were tabulated, analyzed, and correlated by the study au-
thors with nationwide inﬂ  uenza surveillance reports from 
CDC (Table 1) (2) for the 2005–06 and 2006–07 inﬂ  uenza 
seasons (1,2,12).
Results
Of 8,449 adults contacted, 7,268 (86%) agreed to par-
ticipate in the survey. Participants were from representative 
socioeconomic and racial/ethnic groups (Table 3) across 
the United States. The overall monthly participation rate 
was 83%–87%. Participation rates for men and women 
were similar.   
Of the 7,268 adults surveyed by telephone during 7 
surveys (CDC weeks 17–41), 2,337 (32%) said that they 
had cats in the home, 184 (2.5%) lived in close contact with 
chickens, and 230(3.2%) answered “yes” when asked “Do 
you have the ﬂ  u?” Of the 230 adults who answered yes to 
having the ﬂ  u, only 49 (21%) reported having received an 
annual inﬂ  uenza vaccine, 68 (30%) reported having fever 
or abnormal body temperatures, 93 (40%) reported having 
a cough, and 89 (39%) reported having a sore throat (Table 
4). According to CDC inﬂ  uenza surveillance reports for 
weeks 17, 20, and 41 (Table 5), inﬂ  uenza activity nation-
wide peaked in early March 2006 (at approximately week 
10); inﬂ  uenza B virus was the most commonly isolated in-
ﬂ  uenza virus during weeks 17 and 20, and inﬂ  uenza A vi-
rus was the most frequently isolated virus in week 41 (12). 
Data for weeks 21–39 in 2006 were not reported by CDC in 
the 2005–06 and 2006–07 inﬂ  uenza seasons (12).
Discussion
As shown in Table 4, our surveys of 7,268 adult re-
spondents provided nationwide, prepandemic baseline in-
formation about household contact with cats (10) (28%–
37%) and chickens (1%–4%), factors that may be relevant 
to the spread of currently circulating strains of avian inﬂ  u-
enza A (H5N1) virus. The data collected in 7 surveys over 
a 7-month period of low inﬂ  uenza activity were consistent 
with surveillance data gathered and reported by SPN.
More than 80% of persons in the populations and de-
mographic subgroups surveyed nationwide agreed to par-
ticipate in our study; this rate was similar for all regions 
of the country. The rate of self-reported illness from “ﬂ  u” 
ranged consistently from 2% to 5% over the 7-month sur-
vey period, a time of low inﬂ  uenza activity and without 
reported human illnesses from highly pathogenic avian in-
ﬂ  uenza A (H5N1) in the United States. Because only 30% 
(68/230) of respondents who self-reported the ﬂ  u also self-
reported fever, it follows that only a very small fraction 
of all respondents (0.9%, 68/7268) may have met CDC’s 
deﬁ  nition of ILI (i.e., fever [>100°F (37.8°C)] and cough 
or sore throat) (12). Similarly, during the same time frame, 
the SPN reported outpatient ILI rates of 1.2% and 0.9%, 
and the other CDC surveillance systems (Table 5) reported 
only regional and sporadic ILI in most states; moreover, 
none of the CDC-measured indicators suggested that inﬂ  u-
enza-related illness or death were excessive on the dates 
our surveys were conducted. 
A comparison with CDC surveillance data suggests 
that the household telephone survey produced plausible, 
reproducible, and accurate results during a period when the 
circulation of inﬂ  uenza (predominantly inﬂ  uenza B virus) 
in the community was minimal. These results, when inter-
preted in the context of all other applicable surveillance 
reports, suggests that a direct telephone survey of adults at 
home could  improve situational awareness of an inﬂ  uenza 
pandemic.Had unexpected trends or inconsistent rates of 
illness or apparent geographic disparities been identiﬁ  ed, 
an analytic study could have been conducted to suggest 
possible risk factors or further investigations.
According to the DHHS Pandemic Inﬂ  uenza  Plan, 
“Some states are considering the use of systematic phone 
surveys to supplement SPN data during a pandemic by pro-
viding estimates of local cases and affected households. 
CDC will explore the utility and feasibility of conducting 
this type of survey on a national level” (2). In a recent na-
tional telephone survey of 2,075 persons in Sweden, re-
sponses to the question “Did you have the ‘ﬂ  u’ last week?” 
provided useful public health information regarding ongo-
ing inﬂ  uenza disease activity (13). The survey took only 
125 working hours to complete and cost approximately 
€3,250 (US $4,150). On the basis of our results, and as-
suming appropriate IRB approvals are already in place, we 
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estimate that a new questionnaire could be developed in 
conjunction with public health ofﬁ  cials and the telephone 
survey partners within 1 to 2 days, and the surveys could 
be conducted over the next 2 days with results delivered 
essentially immediately to public health ofﬁ  cials. The di-
rect cost of conducting each of the 2- to 3-day telephone 
surveys involving 1,200 adults and asking 10 questions was 
estimated to be $14,000; the 7-survey project in Tables 2–4 
had a direct cost of ≈$98,000. In the United States, CDC 
recently adapted an ongoing national household telephone 
survey project, the Behavioral Risk Factor Surveillance 
System (BRFSS), to measure and monitor inﬂ  uenza vacci-
nation coverage during the 2004–05 inﬂ  uenza season (14). 
CDC surveyed 26,526 adults during February 1–27, 2005 
(14), and reported that ≈6,363 (24%) had been vaccinated. 
This CDC study also showed that inﬂ  uenza vaccination 
coverage among adults through January of the 2004–05 
inﬂ  uenza season was greatest among persons >65 years of 
age (62.7%). In the telephone survey reported here, 21% 
(49/230) of those adults who self-reported the ﬂ  u had re-
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Table 3. Results of a national telephone survey of US adults at home (2006) regarding influenza-like illness, cats, and live chickens in 
the household* 
Survey date 
Information and 
questions
24 Apr 2006 
 (wk 17)
16 May 2006 
 (wk 20)
06 Jun 2006 
(wk 23)
25 Jul 2006
(wk 30)
15 Aug 2006
(wk 33)
14 Sep 2006 
(wk 37)
12 Oct 2006 
 (wk 41)
No. participants/no. 
surveyed (%)
1,039/1,209
(86)
1,036/1,200
(86)
1,068/1,205
(89)
1,031/1,200
(86)
1,048/1,214
(86)
1,001/1,210
(83)
1,045/1,211
(86)
No. participants who answered “yes” to the following (%) 
“Do you have the flu?” 41 (4) 32 (3) 30 (3) 46 (5) 23 (2) 23 (2) 35 (3)
“Do you have any 
cats?”
379 (37) 316 (30) 298 (28) 331 (32) 354 (34) 330 (33) 330 (32)
“Do you have any 
chickens?”
21 (2) 15 (1) 39 (4) 44 (4) 18 (2) 14 (1) 33 (3)
Sex, no. participants/no. surveyed (%) 
  Male 514/583 (88) 491/578 (85) 509/581 (88) 492/578 (85) 509/585 (87) 492/583 (84) 520/584 (89)
  Female 525/626 (84) 545/662 (82) 558/624 (90) 539/622 (87) 539/629 (86) 509/627 (81) 526/627 (84)
Age, y, no. participants/no. surveyed (%) 
  18–29 195/239 (82) 186/237 (78) 198/237 (83) 188/236 (80) 192/236 (81) 207/236 (88) 211/237 (89)
  30–49 418/477 (88) 425/475 (90) 438/474 (92) 416/472 (88) 422/472 (89) 395/472 (84) 416/474 (88)
  50–64 248/274 (90) 247/273 (90) 240/273 (88) 250/271 (92) 244/272 (90) 227/272 (84) 242/273 (89)
>65 165/203 (82) 169/202 (84) 176/200 (88) 165/201 (82) 164/201 (82) 153/201 (76) 153/201 (76)
Ethnicity, no. participants/no. surveyed (%) 
  White 787/896 (88) 763/878 (87) 795/887 (89) 765/879 (87) 775/884 (88) 733/884 (83) 769/885 (87)
  Hispanic 96/119 (81) 90/119 (76) 107/120 (89) 93/119 (78) 104/120 (87) 105/119 (88) 101/120 (84)
  African American 106/131 (81) 117/131 (89) 115/132 (87) 121/131 (92) 103/131 (79) 100/131 (76) 116/132 (88)
  Asian 19/24 (79) 21/24 (88) 23/24 (96) 20/24 (83) 18/24 (75) 19/24 (79) 20/24 (83)
  Other 19/24 (79) 33/36 (92) 24/36 (67) 24/36 (67) 33/36 (92) 30/36 (83) 27/36 (75)
Marital status and children, no. participants/no. surveyed (%) 
  Married 594/676 (88) 556/654 (85) 582/651 (89) 576/644 (89) 567/656 (86) 597/688 (87) 606/702 (86)
  Children in home 336/385 (87) 334/385 (87) 406/442 (92) 351/393 (89) 343/389 (88) NA NA
Home locale, no. participants/no. surveyed (%) 
  Large city 259/292 (89) 285/322 (89) 286/326 (88) 262/313 (84) 267/292 (91) 273/332 (82) 296/341 (87)
  Small city 270/342 (79) 300/355 (85) 265/317 (84) 281/343 (82) 280/332 (84) 310/382 (81) 282/327 (86)
  Suburb 230/259 (89) 161/186 (87) 223/231 (97) 211/235 (90) 171/203 (84) 182/213 (85) 205/228 (90)
  Rural 270/312 (87) 279/325 (86) 283/319 (89) 262/290 (90) 327/380 (86) 232/275 (84) 257/302 (85)
Region, no. participants/no. surveyed (%) 
  East 244/278 (88) 242/276 (88) 250/277 (90) 239/276 (87) 243/279 (87) 234/278 (84) 239/279 (86)
  South 263/314 (84) 278/312 (89) 262/313 (84) 274/312 (88) 266/316 (84) 284/315 (90) 276/315 (88)
  Central 328/375 (88) 324/372 (87) 325/374 (87) 324/372 (87) 318/376 (85) 277/375 (74) 323/375 (86)
  West 204/242 (84) 192/240 (80) 231/241 (96) 194/240 (81) 220/243 (91) 206/242 (85) 207/242 (86)
Education, no. participants/no. surveyed (%) 
  Less than high 
school
345/52 (87) 213/240 (89) 178/240 (74) 191/240 (80) 210/242 (87) 180/241 (75) 205/242 (85)
 High  school 
graduate
221/265 (84) 266/335 (79) 304/336 (90) 279/336 (83) 285/339 (84) 273/338 (81) 297/339 (88)
  Some college 306/356 (86) 250/276 (91) 259/276 (94) 242/276 (88) 236/278 (85) 238/278 (86) 241/278 (87)
  More than college 466/534 (87) 305/347 (88) 323/348 (93) 318/348 (91) 314/351 (90) 308/350 (88) 300/351 (86)
*Data regarding annual income available from authors upon request. NA, not available. Telephone Survey to Assess Inﬂ  uenza-like Illness
ceived an annual inﬂ  uenza vaccine. The rates of inﬂ  uen-
za immunization reported in our August, September, and 
October 2006 surveys were lower than those in the early 
months of 2006, possibly because the 2006–07 trivalent 
immunizations were not yet available through healthcare 
providers at that time; however, this trend in coverage was 
similar to the monthly coverage trends reported by CDC’s 
BRFSS in 2004–05 (14).
Commercial polling agencies already elicit personal 
information from the public on an ongoing basis. Recent-
ly, as demonstrated by its adaptation of the BRFSS sys-
tem, CDC was able to obtain information in response to 
a new public health problem by adding a few questions to 
an existing telephone survey. Although this adaptation of 
the survey, data analysis, and reporting infrastructure of 
the BRFSS appears to have been successful for determin-
ing inﬂ  uenza health status, it has apparently not yet been 
translated into a permanent surveillance system or ongoing 
capability. Moreover, the BRFSS might be overwhelmed in 
a pandemic emergency and, on very short notice, be forced 
to use additional telephone surveys that exist in the private 
and academic sectors. The adaptation of a private opinion 
survey company’s capabilities in partnership with an aca-
demic medical center through approved protocols could 
create a feasible, safe, inexpensive, ﬂ  exible, and acceptable 
way of deriving public health information in emergencies 
and improving situational awareness.
Our study has several limitations. First, the tele-
phone surveys were conducted only during months with 
low inﬂ  uenza activity in 2006. Second, although 7,268 
adults were asked if they had “the ﬂ  u,” only those who 
responded afﬁ  rmatively (230 adults) were asked further 
questions about their inﬂ  uenza vaccination status and the 
presence of fever, cough, and sore throat. Biases may 
have been introduced based on the sequential approach to 
these questions, because some persons with fever, cough, 
or sore throat may have been misclassiﬁ  ed by answering 
“No” to have the ﬂ  u; additional follow-up questions about 
these ILI-related symptoms were not asked of all those 
surveyed. Third, this study had limitations similar to those 
of CDC’s BRFSS: 1) being a land-line telephone–based 
survey, our study excluded adults in households without 
telephones and adults who use only cellular telephones; 
and 2) because the data were self-reported and subject to 
recall bias, especially for questions that required recall 
over a longer period, frequency estimates might be less 
precise for some conditions or behaviors. Fourth, our esti-
mates of the proportion of adults with nondirectory-listed 
telephone numbers including those who had ILI (12) were 
based on unmeasured self-reported temperatures (13) 
rather than on direct observations by healthcare provid-
ers, as in the SPN intended for ambulatory populations 
in healthcare facilities and clinics. Fifth, other illnesses 
and other viral infections besides inﬂ  uenza can cause ILI 
and can be accompanied by fever, cough, or sore throat. 
Finally, there was no laboratory conﬁ  rmation of inﬂ  uenza 
or ILI in our survey participants. 
Nonetheless, we were able to analyze our data in 
terms of self-reported fever, cough, or sore throat, there-
by enabling us to estimate the proportion of respondents 
who met CDC’s deﬁ  nition of ILI (12,13). This capability 
might be useful during an actual pandemic, when it might 
be more desirable to assess the health status of patients by 
telephone (15) rather than exposing these and other patients 
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Table 4. Health status information for patients answering “yes” to “Do you have the flu?” and possible risk factors for pandemic
influenza illness, United States, 2006 
Survey date
Information and questions 
24 Apr 2006 
 (wk 17)
16 May 2006 
(wk 20)
06 Jun 2006 
(wk 23)
25 Jul 2006
(wk 30)
15 Aug 2006
(wk 33)
14 Sep 2006 
(wk 37)
12 Oct 2006 
(wk 41)
No. participants in survey 1,039 1,036 1,068 1,031 1,048 1,001 1,045
No. who answered “yes” to 
“Do you have the flu?”
41 32 30 46 23 23 35
If answered “yes” to “Do you have the flu?” self-responded “yes” to the following, no. (%) 
 Annual  influenza 
vaccination
12 (29) 14 (44) 14 (47) 30 (65) 5 (22) 2 (9) 2 (6)
 Elevated  body 
temperature
11 (27) 22 (69) 9 (30) 7 (15) 1 (4) 13 (57) 5 (14)
  Contact with others having 
flu
16 (39) 6 (19) 14 (47) 24 (52) 13 (57) 8 (35) 3 (9)
  Cough 15 (37) 12 (38) 16 (53) 24 (52) 5 (22) 10 (44) 11 (31)
  Aches 23 (56) 25 (78) 9 (30) 32 (70) 9 (39) 16 (70) 7 (20)
  Chills 9 (22) 3 (9) 4 (13) 21 (46) 9 (39) 10 (43) 9 (26)
  Runny nose 22 (54) 23 (72) 8 (27) 23 (50) 5 (22) 14 (61) 9 (26)
  Short-windedness 9 (22) 7 (22) 8 (27) 29 (63) 12 (52) 9 (39) 2 (6)
  Sore throat 15 (37) 22 (69) 5 (17) 23 (49) 8 (35) 6 (26) 10 (29)
  Southeast Asia travel 0 (0) 1 (3) 0 (0) 19 (41) 2 (9) 1 (4) 1 (3)
  Illness duration <10 days 24 (59) 21 (66) 16 (53) 26 (57) 7 (30) 18 (78) 20 (57)RESEARCH
and healthcare workers to the risk for healthcare-associated 
transmission of respiratory pathogens in clinical settings. 
Although the SPN’s nationwide estimate of ILI, determined 
using CDC criteria, was similar to our telephone survey-
based estimate for the periods of low inﬂ  uenza activity in 
2006, more data are needed to assess the performance of 
these methods during seasonal inﬂ  uenza peaks and during a 
pandemic. Others have suggested that sentinel surveillance 
studies typically underestimate inﬂ  uenza in a population; 
thus, telephone surveys may prove to be an increasingly 
important component of inﬂ  uenza surveillance (13).
Conclusion
Telephone surveys might offer a practical solution to 
addressing the gaps in knowledge of inﬂ  uenza health sta-
tus that might arise during a pandemic. Further telephone 
surveys should be performed during the peak inﬂ  uenza sea-
son to determine whether such an approach to surveillance 
would be a useful addition to ongoing inﬂ  uenza surveil-
lance systems. The usefulness of the telephone survey to 
gain inﬂ  uenza immunization history and current ILI infor-
mation on all people at risk should also be explored. 
Acknowledgments
We thank L. Tirado, J. Zogby, C. Bohnert, P. Hendrix, K. 
Wyborski, and J. Gaydos for technical support; and D. Wenner, 
A. Townley, and J. Richard for editorial support.
Dr Malone is an infectious diseases specialist and medical of-
ﬁ  cer for the US Department of State, Ofﬁ  ce of Medical Services, 
and an associate professor at Uniformed Services University of 
the Health Sciences, Bethesda, MD. His research interests include 
infectious disease, infection control, epidemiology, tropical medi-
cine, disease surveillance, public health response, and interagency 
interface and cooperation.
References
  1.   US Homeland Security Council. National Strategy for Pandemic In-
ﬂ  uenza Implementation Plan. 2006 May [cited 2006 Nov 26]. Avail-
able from   http://www.whitehouse.gov/homeland/nspi_implemen-
tation.pdf 
134  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 1, January 2008
Table 5. Summary of CDC national influenza surveillance reporting, United States, 2006* 
Survey date† Influenza surveillance 
system Data reported 29 Apr 2006 (wk 17) 20 May 2006 (wk 20) 14 Oct 2006 (week 41)
Sentinel Provider Network 
(SPN)
Outpatient visits ILI rate = 1.2% (<2.2% 
national baseline)
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national baseline)
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causes of death
7.1% < threshold 7.8% 6.3% < threshold 7.4% 5.6% < threshold 6.38%
National Notifiable Disease 
Surveillance System 
Seasonal influenza-
associated pediatric 
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state health departments
30 35 0
State and Territorial 
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states; no Activity in 25 
states
Local activity in 2 states 
(AL, HI); sporadic activity 
in 6 states (CA, ID, TX, 
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43 states
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System  
Predominant circulating 
virus
Influenza B Influenza B Influenza A
US WHO and Global 
Influenza Surveillance 
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Respiratory and Enteric 
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(NREVSS)
Percentage of laboratory 
specimens positive and ILI 
positive for influenza virus
9.4 6.3 1.0
*CDC, Centers for Disease Control and Prevention; ILI, influenza-like illness as defined by CDC (6, 12); WHO, World Health Organization. 
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